177 related articles for article (PubMed ID: 30371983)
1. Does chronic immunosuppressive therapy for autoimmune disease influence the risk of developing active tuberculosis?
Bardazzi F; Leuzzi M; Ferrara F; Patrizi A; Loi C
Dermatol Ther; 2019 Jan; 32(1):e12777. PubMed ID: 30371983
[No Abstract] [Full Text] [Related]
2. Recurrence of active tuberculosis following resumption of anti-TNF-α therapy in a patient with Crohn's disease.
Masiá M; Martínez M; García-Sepulcre MF; Sáez J; Gutiérrez F
Int J Tuberc Lung Dis; 2014 Feb; 18(2):249-50. PubMed ID: 24429322
[No Abstract] [Full Text] [Related]
3. Everolimus-induced activation of latent
Jeon SY; Yhim HY; Lee NR; Song EK; Kwak JY; Yim CY
Korean J Intern Med; 2017 Mar; 32(2):365-368. PubMed ID: 26837008
[No Abstract] [Full Text] [Related]
4. What defines latent infection with Mycobacterium tuberculosis in patients with autoimmune diseases?
Sester M; Kampmann B
Thorax; 2016 Jan; 71(1):3-4. PubMed ID: 26678433
[No Abstract] [Full Text] [Related]
5. Tuberculosis and biologics in rheumatology: A special situation.
Handa R; Upadhyaya S; Kapoor S; Jois R; Pandey BD; Bhatnagar AK; Khanna A; Goyal V; Kumar K
Int J Rheum Dis; 2017 Oct; 20(10):1313-1325. PubMed ID: 28730751
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium tuberculosis: Active disease and latent infection in a renal transplant cohort.
Rafiei N; Williams J; Mulley WR; Trauer JM; Jenkin GA; Rogers BA
Nephrology (Carlton); 2019 May; 24(5):569-574. PubMed ID: 29660203
[TBL] [Abstract][Full Text] [Related]
7. Tuberculin Skin Test and Quantiferon in BCG Vaccinated, Immunosuppressed Patients with Moderate-to-Severe Inflammatory Bowel Disease.
Kurti Z; Lovasz BD; Gecse KB; Balint A; Farkas K; Morocza-Szabo A; Gyurcsanyi A; Kristof K; Vegh Z; Gonczi L; Kiss LS; Golovics PA; Lakatos L; Molnar T; Lakatos PL
J Gastrointestin Liver Dis; 2015 Dec; 24(4):467-72. PubMed ID: 26697573
[TBL] [Abstract][Full Text] [Related]
8. A Case of Miliary Tuberculosis Presenting with Whitlow of the Thumb.
Larcher R; Sotto A; Mauboussin JM; Lavigne JP; Blanc FX; Laureillard D
Acta Derm Venereol; 2016 May; 96(4):560-1. PubMed ID: 26554624
[No Abstract] [Full Text] [Related]
9. Multi-focal tuberculous osteomyelitis in a kidney transplant patient.
Padmavathi Devi SV; Harikrishna Reddy M; Sangeetha Lakshmi B; Anil Kumar CV; Ram R; Siva Kumar V
Nephrology (Carlton); 2018 Mar; 23(3):288-289. PubMed ID: 29461003
[No Abstract] [Full Text] [Related]
10. Incidence, Outcomes, and Long-term Immune Response to Tuberculosis in Organ Transplant Recipients.
Natori Y; Ferreira VH; Nellimarla S; Husain S; Rotstein C; Humar A; Kumar D
Transplantation; 2019 Jan; 103(1):210-215. PubMed ID: 29944616
[TBL] [Abstract][Full Text] [Related]
11. Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real-world clinical experience from India.
Shobha V; Chandrashekara S; Rao V; Desai A; Jois R; Dharmanand BG; Kumar S; Kumar P; Dharmapalaiah C; Mahendranath KM; Prasad S; Daware MA; Singh Y; Karjigi U; Nagaraj S; Anupama KR
Int J Rheum Dis; 2019 Feb; 22(2):280-287. PubMed ID: 30168281
[TBL] [Abstract][Full Text] [Related]
12. Asymptomatic lung disease caused by Mycobacterium kansasii as an opportunistic infection in a patient treated with natalizumab for relapsing-remitting multiple sclerosis.
Hradilek P; Zeman D; Tudik I; Zapletalova O; Ulmann V
Mult Scler; 2014 Apr; 20(5):639-40. PubMed ID: 23959714
[No Abstract] [Full Text] [Related]
13. The hydroxychloroquine-interferon gamma release assay question: TB or not TB?
Heymann WR
J Am Acad Dermatol; 2019 Apr; 80(4):902-903. PubMed ID: 30731169
[No Abstract] [Full Text] [Related]
14. Acquired latent tuberculosis infection in psoriasis patients treated with etanercept in the People's Republic of China.
Li CR; Mao QX; Chen M; Jia WX; Yao X; Feng SY; Jia H; Gong JQ; Yang XY
Drug Des Devel Ther; 2015; 9():5591-4. PubMed ID: 26508833
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of interferon-gamma release assay (T-SPOT.TB(™) ) for diagnosis of tuberculosis infection in rheumatic disease patients.
Jiang B; Ding H; Zhou L; Chen X; Chen S; Bao C
Int J Rheum Dis; 2016 Jan; 19(1):38-42. PubMed ID: 26820838
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis After Renal Transplant.
Barbouch S; Hajji M; Helal I; Ounissi M; Bacha MM; Ben Hamida F; Abderrahim E; Ben Abdallah T
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):200-203. PubMed ID: 28260468
[TBL] [Abstract][Full Text] [Related]
17. Risk of infections associated with biological treatment in inflammatory bowel disease.
Andersen NN; Jess T
World J Gastroenterol; 2014 Nov; 20(43):16014-9. PubMed ID: 25473153
[TBL] [Abstract][Full Text] [Related]
18. Latent tuberculosis infection detection and active tuberculosis prevention in patients receiving anti-TNF therapy: an Italian nationwide survey.
Cantini F; Lubrano E; Marchesoni A; Mathieu A; Olivieri I; Salvarani C; Scarpa R; Spadaro A
Int J Rheum Dis; 2016 Aug; 19(8):799-805. PubMed ID: 26172207
[TBL] [Abstract][Full Text] [Related]
19. Interferon gamma release assays for monitoring the response to treatment for tuberculosis: A systematic review.
Clifford V; He Y; Zufferey C; Connell T; Curtis N
Tuberculosis (Edinb); 2015 Dec; 95(6):639-650. PubMed ID: 26515270
[TBL] [Abstract][Full Text] [Related]
20. Fluoroquinolones for the treatment of latent
Silva JT; San-Juan R; Fernández-Ruiz M; Aguado JM
World J Gastroenterol; 2019 Jul; 25(26):3291-3298. PubMed ID: 31341356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
